The American Society of Clinical Oncology (ASCO) will host its annual meeting in Chicago, from May 29 – June 3. This year’s theme is “The Science and Practice of Translation: Improving Cancer Outcomes Worldwide,” and features more than 2,700 poster presentations, and several oral abstract sessions, clinical science symposia, and case-based panels.
Faculty members representing UNC Lineberger will share their latest research findings and clinical insights during the meeting. In addition to sharing research data, the meeting provides them with an opportunity to meet with research collaborators and connect with colleagues from across the globe.
The UNC Lineberger presentations this year include:
May 29
Presenter: Ashwin Somasundaram, MD
Case-Based Panel
Title: Optimal Multidisciplinary Care for Patients With Nonmetastatic Pancreatic Cancer
May 30
Presenter: Colette Shen, MD, PhD
Poster Session
Title: Reirradiation with NBTXR3/SBRT in combination with nivolumab or pembrolizumab for the treatment of patients with recurrent or metastatic head & neck squamous cell carcinoma (HNSCC) in the phase I trial study 1100
Presenter: Ethan M. Basch, MD, MSc
Poster Session
Title: National implementation of electronic patient-reported outcomes (ePROs) for remote symptom monitoring in oncology: The OncoPRO initiative
Presenter: Hyman B. Muss, MD (co-author)
Poster Session
Title: Estimation of the impact of chemotherapy-induced biological age acceleration on breast cancer survivorship using multi-scale simulation modeling
Presenter: Hyman B. Muss, MD (co-author)
Poster Session
Title: Validation of a 10-item frailty index based on a comprehensive geriatric assessment (FI-CGA-10) for predicting survival in older adults with cancer
May 31
Presenter: Ethan M. Basch, MD, MSc
Oral Session (Clinical Science Symposium)
Title: Elevating the Patient Voice: Choosing the Right Patient-Centered Endpoints in Modern Clinical Trials
Presenter: Gaorav P. Gupta, MD, PhD (senior author)
Clinical Science Symposium
Title: Primary results from the triple-negative cohort of TBCRC-053 (P-RAD): A randomized trial of no, low, or high dose preoperative radiation with pembrolizumab and chemotherapy in node-positive breast cancer
June 1
Presenters: Christopher E. Jensen, MD, MSc, and Hyman B. Muss, MD (co-author)
Poster Session
Title: Utility of a modified geriatric assessment to identify impairments in adults of all ages with lymphoma: A prospective observational cohort study
Presenter: Hyman B. Muss, MD (co-author)
Poster Session
Title: Patient-reported outcomes from the adjuvant ado-trastuzumab emtansine (T-DM1) for older patients with HER2+ breast cancer (ATOP) trial
Presenter: Yara Abdou, MD, MSCR
Poster Session
Title: PREDICT-RD: Postoperative molecular residual disease by ctDNA surveillance in TNBC with residual disease (TBCRC-071)
More information about the research presented, including abstracts, can be found on the ASCO Meeting Content database.